Jamil Khurram insider trades
Jamil Khurram has filed 12 Form 4s with the SEC that we hold, all for Galectin Therapeutics INC (GALT), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 17 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 16 sales ($1.2M). The largest single trade was a sale of 47,467 shares of Galectin Therapeutics INC worth $239.2K, dated 2026-06-29. The first filing on our record is dated 2024-08-05 and the latest 2026-07-16.
Galectin Therapeutics INC (GALT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-23 | S, sale reported on Form 4 | 13,654 | $12.0K | 2024-12-26 |
| 2025-11-13 | S, sale reported on Form 4 | 41,500 | $227.0K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 21,867 | $119.6K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 16,250 | $88.9K | 2025-11-14 |
| 2025-12-17 | S, sale reported on Form 4 | 8,500 | $59.8K | 2025-12-19 |
| 2025-12-17 | S, sale reported on Form 4 | 6,463 | $45.5K | 2025-12-19 |
| 2025-12-17 | S, sale reported on Form 4 | 4,479 | $31.5K | 2025-12-19 |
| 2025-12-31 | S, sale reported on Form 4 | 8,125 | $33.1K | 2026-01-05 |
| 2026-01-02 | S, sale reported on Form 4 | 13,055 | $54.8K | 2026-01-06 |
| 2026-01-05 | S, sale reported on Form 4 | 25,499 | $99.4K | 2026-01-06 |
| 2026-01-06 | S, sale reported on Form 4 | 21,446 | $78.3K | 2026-01-06 |
| 2026-05-26 | S, sale reported on Form 4 | 568 | $1.8K | 2026-05-28 |
| 2026-06-23 | S, sale reported on Form 4 | 7,557 | $23.7K | 2026-06-25 |
| 2026-06-26 | S, sale reported on Form 4 | 2,037 | $10.2K | 2026-06-30 |
| 2026-06-26 | S, sale reported on Form 4 | 2,533 | $12.7K | 2026-06-30 |
| 2026-06-29 | S, sale reported on Form 4 | 47,467 | $239.2K | 2026-06-30 |
| 2026-07-14 | S, sale reported on Form 4 | 16,250 | $83.3K | 2026-07-16 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2032345) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms